December 14 — Canon Medical Systems Corporation and Resoundant Inc. have signed a licensing agreement for the purpose of incorporating the advanced magnetic resonance elastography (MRE), developed by Resoundant on the Canon MRI platforms. Canon Medical and Resoundant have been working closely together to implement a seamless integration of the latest MRE technology on Canon’s newest line of MRI scanners.
“We are excited to continue expanding our applications of body MR imaging by adding this technology that Resoundant has worked so well at establishing and improving. Resoundant is the pioneer in MRE and we are enthusiastic about the possibilities this relationship will bring to our customers.” said Akira Adachi, general manager, MRI Systems Division at Canon Medical
“We’re thrilled to see MRE become available on Canon’s world-class MRI systems,” said Richard Ehman, M.D., professor of radiology and the Blanche R. & Richard J. Erlanger professor of medical research at Mayo Clinic and CEO of Resoundant. “One of our highest priorities is ensuring access to MRE anywhere in the world. Partnering with Canon helps us do that, as their footprint continues to expand rapidly.”
About MRE
MR Elastography was invented at Mayo Clinic and is the only MRI technology that has been validated for staging liver fibrosis. It is currently available to clinicians at over 1,800 locations across the globe. The role of MRE has been increasingly recognized in multidisciplinary clinical guidelines for noninvasive liver fibrosis assessment, particularly in suspected cases of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The American College of Radiology issued Appropriateness Criteria that identify MRE as the most accurate and applicable noninvasive liver fibrosis exam. In the U.S., MRE is reimbursed via a Category I CPT code (76391) and is covered by numerous public and private insurance plans.
For more information: us.medical.canon
January 28, 2026 
